Samsung and AMD Ink Multi-Year Pact To Increase Mobile Graphics Experience

CIOTechOutlook Team | Thursday, 06 April 2023, 06:28 IST

  •  No Image
As part of an extended portfolio of Samsung Exynos SoCs, Samsung Electronics and chipmaker AMD have signed a multi-year partnership extension to offer many generations of high-performance, ultra-low-power AMD Radeon graphics solutions.
 
According to IANS, Through the licensing extension, Samsung will bring console-level graphics quality and optimised power consumption to more mobile devices, offering an incredibly immersive and long-lasting gaming experience.
 
"Drawing on our technological know-how in designing ultra-low-power solutions, we will continue to drive ongoing innovation in the mobile graphics space," said Seogjun Lee, Executive Vice President of Application Processor (AP) Development at Samsung.
 
A mobile graphics processing unit (GPU) based on the AMD RDNA 2 architecture, the Samsung Xclipse, will be developed in conjunction with AMD in 2022 after Samsung and AMD originally announced their agreement to licence AMD RDNA graphics architecture in 2019.
 
With hardware-accelerated ray tracing and variable rate shading for mobile device gameplay similar to that on consoles, Xclipse was the first mobile GPU in the industry.
 
"We are excited Samsung selected multiple generations of our leadership high-performance Radeon graphics to advance the next generation of Samsung Exynos solutions," said David Wang, Senior Vice President of the Radeon Technologies Group at AMD.
 
"The extension of our work with Samsung is a testament to our strong technology partnership and commitment to bring the best experiences possible to mobile users," he added.

On The Deck


CIO Viewpoint

AI Appreciation Day: Powering Smart Factories,...

By Janifha Evangeline, Editor, CIOTechOutlook

Why Foolproof Facial Recognition Is Key Against...

By Joseph Sudheer Thumma, Global CEO & MD, Magellanic Cloud

CXO Insights

GAZING INTO MY CRYSTAL BALL: Healthcare...

By Dr. Vishal Rajgarhia, Director, Finecure Pharmaceuticals Limited, Chairman, ASSOCHAM Pharma Council, Director, Ecuador India Cha

How Intelligent Swabs Saves Lives Post-Surgery

By Dr. Sreeram Srinivasan, CEO, Syrma Technology Private Limited

INTELLIGENT CONNECTED CARE: The Future Of...

By Srinivas Prasad, CEO at Philips Innovation Campus